Home > The misuse of benzodiazepines among high-risk opioid users in Europe (perspectives on drugs).

European Monitoring Centre for Drugs and Drug Addiction. (2018) The misuse of benzodiazepines among high-risk opioid users in Europe (perspectives on drugs). Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 10 p.

[img]
Preview
PDF (The misuse of benzodiazepines among high-risk opioid users in Europe) - Published Version
443kB

URL: http://www.emcdda.europa.eu/publications/pods/benz...


Benzodiazepines are a widely prescribed group of medicines with a range of clinical uses, including the treatment of anxiety and insomnia and the management of alcohol withdrawal. For a number of reasons this group of medicines are often misused by high-risk opioid users and are associated with morbidity and mortality among this group. This analysis considers the significance of this problem and its impact for the health and drug treatment of opioid users.

Part of the Perspectives on Drugs (PODs) series, launched as part of the European Drug Report package, these designed-for-the-web interactive analyses provide deeper insights into a selection of important issues.

Item Type:Evidence resource
Publication Type:Report
Drug Type:CNS depressants
Date:2018
Pages:10 p.
Publisher:European Monitoring Centre for Drugs and Drug Addiction
Corporate Creators:European Monitoring Centre for Drugs and Drug Addiction
Place of Publication:Lisbon
EndNote:View
Accession Number:HRB (Electronic Only)
Subjects:B Drugs and alcohol substances > Sedatives or tranquillisers (CNS depressants) > Benzodiazepine
B Drugs and alcohol substances > Opioids (opiates)
J Health care, prevention and rehabilitation > Risk and protective factors > Risk factors
VA Geographic area > Europe

Repository Staff Only: item control page